Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age.

[1]  S. Salmaso,et al.  Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. , 2001, Pediatrics.

[2]  W. Edmunds,et al.  Immunity to diphtheria and tetanus in England and Wales. , 2000, Vaccine.

[3]  P. Jenum,et al.  Immunity to diphtheria among children in Northern Norway and North-Western Russia. , 2000, Vaccine.

[4]  E. L. Miller,et al.  The sero-epidemiology of diphtheria in Western Europe , 2000, Epidemiology and Infection.

[5]  S. Salmaso,et al.  Diphtheria Antibody Levels in the Italian Population , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[6]  H. Hallander,et al.  Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster. , 2000, Vaccine.

[7]  A. Galazka,et al.  Implications of the diphtheria epidemic in the Former Soviet Union for immunization programs. , 2000, The Journal of infectious diseases.

[8]  M. Pichichero,et al.  Extensive Swelling After Booster Doses of Acellular Pertussis–Tetanus–Diphtheria Vaccines , 2000, Pediatrics.

[9]  E. Hundt,et al.  Diphtheria booster vaccination: one or two injections? , 1999, Vaccine.

[10]  M. Granström,et al.  Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. , 1999, Vaccine.

[11]  C. Gotway,et al.  Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccination , 1999, The Lancet.

[12]  M. Valenciano,et al.  ESEN : a comparison of vaccination programmes Part one: diphtheria. , 1998, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  R. Gupta,et al.  Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. , 1998, Vaccine.

[14]  O. Simonsen,et al.  Fall‐off in immunity following diphtheria revaccination ‐ an 8 year follow‐up study , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  B. No̸rgaard-Pedersen,et al.  Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. , 1996, Journal of immunological methods.

[16]  P. Gergen,et al.  A Population-Based Serologic Survey of Immunity to Tetanus in the United States , 1995 .

[17]  O. Simonsen.  Vaccination against tetanus and diphtheria. Evaluations of immunity in the Danish population, guidelines for revaccination, and methods for control of vaccination programs. , 1989, Danish medical bulletin.

[18]  S. Salmaso,et al.  Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group. , 1999, Bulletin of the World Health Organization.

[19]  W. H. Hattie.  DIPHTHERIA TOXOID. , 1927, Canadian Medical Association journal.